Contracts Finder · Award
PHE - Screening - TB Product Owner: Contract Extension
A public procurement published by Public Health England via Contracts Finder.
- £102k
- Award value
- £102k
- Tender value
- 1
- Suppliers
- 1
- Awards
- 1
- Notices
- Award
- Stage
Overview
The contract between PHE and Aptemus Limited has been extended for a further 12 months for the supply of a Product Owner to oversee developments and enhancements to the PHE ICT TB Screening software.
Key details
- Source
- Contracts Finder
- Lifecycle stage
- Award
- Status
- complete
- CPV classification
- 48000000 — Software package and information systems
- Currency
- GBP
- Total award value
- £102,000
- Tender value
- £102,000
- First published
- 20 Aug 2019
- Last updated
- 20 Aug 2019
Awards
1 award recorded on this procurement.
| Supplier | Companies House | Awarded | Status | Value |
|---|---|---|---|---|
| Aptemus Limited | 09390567 | 19 Aug 2019 | active | £102k |
Notice timeline
Every published notice in this procurement's lifecycle.
All suppliers
Frameworks & programmes
FAQs about this procurement
Who is the buyer for "PHE - Screening - TB Product Owner: Contract Extension"?
PHE - Screening - TB Product Owner: Contract Extension is a UK public-sector procurement published by Public Health England via Contracts Finder.
Has "PHE - Screening - TB Product Owner: Contract Extension" been awarded?
Yes — 1 award is recorded, with a reported total value of £102,000. The current lifecycle stage is "Award".
Which suppliers are involved in "PHE - Screening - TB Product Owner: Contract Extension"?
1 supplier is linked: Aptemus Limited.
What is "PHE - Screening - TB Product Owner: Contract Extension" worth?
The reported award value is £102,000.
When was "PHE - Screening - TB Product Owner: Contract Extension" published?
It was first published on 20 Aug 2019 and last updated on 20 Aug 2019, across 1 notice.
Track procurements like this one
Enable monitors the entire UK public-contract pipeline — get alerts on buyers, suppliers and frameworks that matter to you.
Get in touch with Enable